Neurology Trials

  • Artificial Intelligence in Brain Tumour Imaging

    View Trial
  • 31/01/2015

    International Guillain-Barre Syndrome Outcome Stud

    Clinical and biological determinants of disease course in Guillain-Barre syndrome: a prospective UK-wide observational study interfacing with the International Guillain-Barre syndrome Outcome Study – IGOS

    View Trial
  • 31/12/2019

    FIND

    Fatigue In Neuropathic Disorders

    View Trial
  • 31/12/2017

    Functional Imaging of Tumours

    View Trial
  • 31/08/2021

    DexEnceph

    Dexamethasone in Herpes Simplex Virus Encephalitis Randomised Controlled Trial and Non- HSV Cohort Study

    View Trial
  • A pilot study investigating CSF findings and clinical associations in autoimmune encephalitis

    View Trial
  • 30/06/2020

    Adapt

    A Randomized Double-Blind Placebo-Controlled Multicenter Phase 3 Trial to Evaluate the Efficacy Safety and Tolerability of ARGX-113 in Patients with Myasthenia Gravis Having Generalized Muscle Weakness

    View Trial
  • 30/04/2020

    MOM-M281-004

    A Phase 2 Multicenter Randomized Double-Blind Placebo-Controlled Study to Evaluate the Safety Tolerability Efficacy Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults with Generalized Myasthenia Gravis

    View Trial
  • 01/10/2018

    Patients’ and physicians’ experiences of decision-making in Multiple Sclerosis: A multi-perspective IPA design

    View Trial
  • 30/08/2029

    OBS13434 (PASS)

    A prospective multicenter observational post-authorization safety study (PASS) to evaluate the long term safety profile of LEMTRADA® (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis (RMS)

    View Trial